10:51 am Intersect ENT (XENT)
With it being a slow day today after Christmas, we thought it'd be a good idea to look back at some IPOs in 2014 that may have gotten overlooked by some investors and present them to you. One name that is worth a look is Intersect ENT (XENT). It's a commercial stage drug-device company that has developed a drug-eluting bioabsorbable implant technology.
Its initial products, PROPEL and PROPEL mini, are the first and only drug-eluting implants approved by the FDA for use in patients with chronic sinusitis. Inserted by a physician during sinus …More